SANDOZ DIMETHYL FUMARATE DIN 02515563
Health Canada record
| Active ingredient(s) | DIMETHYL FUMARATE 120 MG |
|---|---|
| Dosage form | Capsule (Delayed-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L04AX07 DIMETHYL FUMARATE |
| Original market date | |
| Current status date | 31-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIMETHYL FUMARATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02505762 | APO-DIMETHYL FUMARATE | APOTEX INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Marketed |
| 02505770 | APO-DIMETHYL FUMARATE | APOTEX INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Marketed |
| 02540754 | AURO-DIMETHYL FUMARATE | AURO PHARMA INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Marketed |
| 02540746 | AURO-DIMETHYL FUMARATE | AURO PHARMA INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Marketed |
| 02516055 | JAMP DIMETHYL FUMARATE | JAMP PHARMA CORPORATION | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Marketed |
| 02516047 | JAMP DIMETHYL FUMARATE | JAMP PHARMA CORPORATION | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Marketed |
| 02502690 | MAR-DIMETHYL FUMARATE | MARCAN PHARMACEUTICALS INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Marketed |
| 02502704 | MAR-DIMETHYL FUMARATE | MARCAN PHARMACEUTICALS INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Marketed |
| 02497034 | PMS-DIMETHYL FUMARATE | PHARMASCIENCE INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Marketed |
| 02497026 | PMS-DIMETHYL FUMARATE | PHARMASCIENCE INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Marketed |
| 02404508 | TECFIDERA | BIOGEN CANADA INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Marketed |
| 02420201 | TECFIDERA | BIOGEN CANADA INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Marketed |
| 02495368 | ACH-DIMETHYL FUMARATE | ACCORD HEALTHCARE INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Cancelled Post Market |
| 02495341 | ACH-DIMETHYL FUMARATE | ACCORD HEALTHCARE INC | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Cancelled Post Market |
| 02494809 | GLN-DIMETHYL FUMARATE | GLENMARK PHARMACEUTICALS CANADA INC. | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Dormant |
| 02494817 | GLN-DIMETHYL FUMARATE | GLENMARK PHARMACEUTICALS CANADA INC. | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Dormant |
| 02515571 | SANDOZ DIMETHYL FUMARATE | SANDOZ CANADA INCORPORATED | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Cancelled Pre Market |
| 02513781 | SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES | SANDOZ CANADA INCORPORATED | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Dormant |
| 02513803 | SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES | SANDOZ CANADA INCORPORATED | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Dormant |
| 02493594 | TEVA-DIMETHYL FUMARATE | TEVA CANADA LIMITED | Capsule (Delayed-Release) | DIMETHYL FUMARATE 240 MG | Cancelled Pre Market |
| 02493586 | TEVA-DIMETHYL FUMARATE | TEVA CANADA LIMITED | Capsule (Delayed-Release) | DIMETHYL FUMARATE 120 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 26781 | 2021-10-04 | Abbreviated New Drug Submission (ANDS) |
International API supply for DIMETHYL FUMARATE
29 active FDA Drug Master Files.
Request a quote for SANDOZ DIMETHYL FUMARATE